Suchergebnisse

VAREX IMAGING (VREX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates

Skillsoft Corp. (SKIL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates --

Gerdau (GGB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most

Kolibri Global Energy Inc. (KGEI) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates

Kyntra Bio (KYNB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the

The Zacks Utility - Electric Power industry, supported by its regulated structure offer, stable returns and long-term earnings. Utilities operate under a regulated framework, enabling companies to

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't

Shares of Uber Technologies UBER) have declined 23.4% over the past six months against the Zacks  Internet-Services industry’s growth of 20.7%. However, it outperformed fellow industry players, Lyft

Kymera Therapeutics KYMR announced that the FDA has granted a Fast Track designation to its lead candidate, KT-621, for the treatment of moderate-to-severe eosinophilic asthma. KYMR shares rose 4%

Nu Holdings Ltd. NU is currently trading at a 16.1X forward 12-month price-to-earnings, substantially higher than the industry’s 10.91X. While the stock appears expensive, the forward-looking

Invesco S&P 500 Momentum ETF SPMO is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 46.84% from its 52-week low price of $84.86 per share.

Peloton (PTON) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its

Murphy Oil (MUR) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with

Merck MRK and its Japanese partner Daiichi Sankyo announced that the FDA has accepted the biologics license application (BLA) seeking approval for ifinatamab deruxtecan (I-DXd), a B7-H3-directed DXd

HSBC Holdings plc HSBC has introduced its Tokenized Deposit Service (TDS) in the United States to enable faster and smoother money transfers using blockchain technology. The move represents the

Terreno Realty Corporation TRNO announced that it recently completed the development and stabilization of Countyline Corporate Park Phase IV Building 34 in Hialeah, FL, for a total investment of

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Corpay (CPAY)

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Royalty Pharma

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Ally Financial (ALLY), which belongs to